DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stock Now Rated “Hold” by Wall Street Brokerages

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have earned a consensus rating of “Hold” from the fourteen analysts that are presently covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and three have given a buy recommendation to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $12.62.

XRAY has been the subject of a number of research reports. BMO Capital Markets lowered their price target on DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating for the company in a research report on Thursday, September 17th. Piper Sandler cut their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, October 9th. Mizuho cut their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Thursday, October 22nd. Barrington Research reduced their price objective on DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating for the company in a research note on Monday. Finally, Barclays lifted their target price on DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a report on Monday, August 24th.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of institutional investors have recently bought and sold shares of XRAY. Blue Trust Inc. raised its holdings in DENTSPLY SIRONA by 10.8% during the first quarter. Blue Trust Inc. now owns 12,555 shares of the medical instruments supplier’s stock worth $146,000 after purchasing an additional 1,226 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its position in DENTSPLY SIRONA by 3.3% in the first quarter. Oregon Public Employees Retirement Fund now owns 40,944 shares of the medical instruments supplier’s stock valued at $475,000 after purchasing an additional 1,300 shares during the period. Allworth Financial LP lifted its position in DENTSPLY SIRONA by 163.8% in the second quarter. Allworth Financial LP now owns 4,815 shares of the medical instruments supplier’s stock valued at $51,000 after purchasing an additional 2,990 shares during the period. Nykredit A S purchased a new stake in DENTSPLY SIRONA in the 2nd quarter valued at approximately $38,000. Finally, IFP Advisors Inc boosted its holdings in DENTSPLY SIRONA by 244.4% in the 3rd quarter. IFP Advisors Inc now owns 5,566 shares of the medical instruments supplier’s stock valued at $49,000 after purchasing an additional 3,950 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $9.22 on Thursday. The firm has a market capitalization of $1.84 billion, a P/E ratio of -3.35, a PEG ratio of 1.20 and a beta of 0.87. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. The company has a 50 day moving average price of $9.82 and a 200 day moving average price of $11.40. DENTSPLY SIRONA has a 52 week low of $8.32 and a 52 week high of $14.76.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.17. The company had revenue of $898.00 million for the quarter, compared to the consensus estimate of $889.93 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. DENTSPLY SIRONA’s revenue was down 4.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.52 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Sell-side analysts expect that DENTSPLY SIRONA will post 1.39 EPS for the current year.

About DENTSPLY SIRONA

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.